dalteparin has been researched along with Adrenal Gland Hypofunction in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenberger, LH | 1 |
| Smith, PW | 1 |
| Sawyer, RG | 1 |
| Schneider, F | 1 |
| Assemi, P | 1 |
| Ba Faye, A | 1 |
| Sauer, B | 1 |
| Lutun, P | 1 |
2 other studies available for dalteparin and Adrenal Gland Hypofunction
| Article | Year |
|---|---|
Heparin-induced thrombocytopenia: an increasingly common cause of bilateral adrenal hemorrhage.
Topics: Adrenal Gland Diseases; Adrenal Glands; Adrenal Insufficiency; Aged; Anticoagulants; Arthroplasty, R | 2011 |
[A puzzling circulatory failure after total hip replacement].
Topics: Acute Disease; Adrenal Insufficiency; Anticoagulants; Arthroplasty, Replacement, Hip; Enoxaparin; Fe | 2003 |